Services Overview

We act as your agent, representative, interim or mentor/coach. We can set up your company in Japan. We are dedicated to making your commercial success real!

We supply the market intelligence you need to be successful in Japan!

We connect you with the right Japanese companies within Biopharma, ATMP, CGT, Regenerative Medicine, Pharmaceuticals, Combination Devices, IVD’s, Universities and distributors. The right mix you need among: Trade Shows, KOLs, customers, partners, distributors . . .

A handshake under the Rising Sun of Japan.

Biosector = Commercialization in Japan

Preparation and reports – What you need to know!

We produce your feasibility studies and all other types of reports that you need to unlock your commercial pathway into Japan’s Pharmaceutical Industry. We help pave every step of your commercialization process.

Download for free:

You need: fast, accurate and actionable reports, feasibility studies, target lists and analysis to be able to draw up the best strategies.

We supply: just that!

By partnering with Biosector, you get the upper hand!

Market Entry: Seamless Integration and Strategic Positioning

Your success in Japan requires the following keys:

  1. Budget
  2. Cultural competence
  3. Clear goals
  4. Strategic approach
  5. Feet on the ground
  6. Long term mindset
  7. Patience
  8. Consistency


We make sure you are moving as fast as possible and that your expectations are aligned with those of your future clients and partners’ in Japan.

Market Expansion: Optimizing Your New Commercial Opportunities and Accelerating Growth

Expanding your footprint in Japan is crucial. Accelerating your growth successfully equals long-term success. You need competence and excellence: we supply! You need to optimize your new avenues for growth – we support you! We assist you in making sure of your new market segments and their strategies.

Leveraging your opportunities through our extensive industry connections is a valuable shortcut.

With Biosector, you have the advantage that only comes with exceptional professionals. Every step of the way.

About Stefan Sandström 

CEO of Biosector Ltd. Residence

Residence: Based in Metropolitan Tokyo since 2007.

Unique Perspective: Science and business.

Education: Medicine and chemical engineering.

Leadership: Successfully led multiple industrial companies as CEO.

Accreditations: Accredited business consultant via  German RKW.

Collaborations: Japanese partner to notable entities:  SPECTARIS and Kalms Consulting.

Recognitions: Appointed as an expert on conducting business in Japan by the EU-Japan Centre for Industrial Cooperation.

Track Record: Three decades of experience in international and cross-border business development, achieving first sales.

Passion: Kendo (martial art) with the rank of 6 dan.

Testimonials/Cases

Dan Spacie

CEO of MAP Patient Access, UK

”I have worked with Stefan Sandström outside of Biosector for over a year and will continue to work with him in Biosector. This is an exceptionally highly skilled partner, walking the extra mile and having made all the difference for building our traction in Japan.”

Anne-Kathrin Schmalz

Senior Manager Foreign Trade and Export Promotion

”Mr Sandström delivered an amazing seminar for our members in Sep 2021. He combined extensive specialist knowledge of the Japanese bio and laboratory market and how to bridge cultural differences. ”

Tony White

“Biosector’s business intelligence has helped me identify investment opportunities I would never have discovered. They deliver incisive analysis applying the Pareto Principle, allowing me to make fast decisions and save huge amounts of time. A great help for guiding the next steps forward.” – Tony White, founder of BioPhorum and angel investor

Blog

Illustration of a rejected pharmaceutical batch for import into Japan.
Japan represents one of the world’s most demanding pharmaceutical markets, with rigorous quality standards that go beyond technical specifications. They include precise visual and cultural expectations. For CDMOs, exporting pharmaceuticals to Japan means it’s necessary to understand the complexity of the release process. The PMDA enforces […]
Illustration depicting ATMP classification and market entry strategies in Japan.
Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biotechnology, offering transformative therapeutic solutions for various complex medical conditions. However, the classification of what qualifies as an ATMP is a maze. It involves stringent regulatory criteria that differentiate these therapies from traditional biologics. Let’s […]
Illustration showing the financial barriers to accessing Cell and Gene Therapies.
The rise of Cell and Gene Therapies (CGT) marks a significant advancement in modern medicine, offering cures for previously untreatable conditions. However, the financial burden of these innovative treatments raises profound questions about their accessibility and the broader implications for global health equity. This reality most […]
A modern flat-style illustration of a futuristic Japanese cityscape with healthcare icons like diagnostic equipment, DNA strands, and molecular structures integrated into the skyline. A bridge symbolizes market entry, with business professionals and healthcare workers navigating it. On one side, regulatory documents represent challenges, while on the other, the thriving healthcare market and technology advancements represent growth and opportunity. The image uses bright colors and clean lines.
Japan’s IVD market presents a significant opportunity for international companies expanding into Asia. The advanced healthcare infrastructure and growing demand for innovative diagnostic solutions make Japan an attractive market for IVD products. However, entering this market requires a strategic approach, understanding the local dynamics, and navigating […]
A Mediterranean architectural illustration with old-fashioned electric bulb-lamps and classic "Eureka" symbols representing new ideas.
Innovation is often misunderstood as merely the introduction of new ideas or products. Even more frequently, it’s misinterpreted as the most important step towards a successful market introduction. However, true innovation extends far beyond invention; it involves transformative changes that fundamentally alter business models and market […]
A man, Stefan Sandstrom, is giving a keynote speech at the BioStock Global Forum 2024. He is dressed in a black blazer and a patterned shirt, holding a clicker in one hand and gesturing with the other. He is wearing a headset microphone and has a lanyard with a name badge that reads "PRESENTER" around his neck. The background shows the event's stage with curtains.
BioStock Global Forum 2024 – May 30, Part II Watch the keynote speech, including the Q&A session on  YouTube. Welcome to an in-depth look at the BioStock Global Forum 2024, where industry leaders gather to share insights and innovations shaping the future of healthcare. In this […]

Please feel warmly welcome to contact us:

email: info@biosector.jp
phone: +81 80-3404-8431

Address: Yokohama Landmark Tower, 20th Floor, 2-2-1 Minatomirai, Nishi-ku, 〒220-8120,

Yokohama, JAPAN

Deliveries: Kosugaya 1-20-6-202, Sakae-ku, 〒247-0007, Yokohama, JAPAN